EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Navigating the Gut–Prostate Axis: The Gut Microbiome in Prostate Cancer Resistance and Targeted Interventions

Zeyu Ai, Ping Dai, Kangnan He, Ruilong Nie, Shimin Zou, Liang Chen

Microbiology Research · 05.03.2026 · 17 (3) · 55

DOI: 10.3390/microbiolres17030055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Research, online erschienen am 05.03.2026. Verfasst von Zeyu Ai und 5 weiteren Autor:innen. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the gut microbiome has been increasingly recognized as an important factor in regulating treatment responses and disease progression in prostate cancer (PCa). We synthesized literature published over the past five years, focusing on preclinical and clinical studies linking the microbiome to PCa treatment outcomes. There is accumulating evidence that gut microbiota dysbiosis and its associated metabolites can modulate key biological processes, such as androgen metabolism, inflammatory signaling pathways, and antitumor immune responses. These processes affect the sensitivity of PCa patients to androgen deprivation therapy (ADT) and other systemic treatments. The available evidence suggests that the gut microbiome has the potential to serve as a predictive biomarker for treatment response and could represent a novel target for interventional precision therapy in PCa. This narrative review summarizes the latest research on the “gut–prostate axis”, focusing on the role of the gut microbiome in regulating therapeutic responses in PCa and the underlying mechanisms. Finally, we address current limitations, including the predominance of preclinical evidence, methodological heterogeneity, and the critical need for longitudinal clinical validation to distinguish causality from association.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ai, Z., Dai, P., He, K., Nie, R., Zou, S., & Chen, L. (2026). Navigating the Gut–Prostate Axis: The Gut Microbiome in Prostate Cancer Resistance and Targeted Interventions. Microbiology Research, 17(3), 55. https://doi.org/10.3390/microbiolres17030055

Vancouver

Ai Z, Dai P, He K, Nie R, Zou S, Chen L. Navigating the Gut–Prostate Axis: The Gut Microbiome in Prostate Cancer Resistance and Targeted Interventions. Microbiology Research. 2026;17(3):55. doi:10.3390/microbiolres17030055

BibTeX
@article{Ai2026,
  author = {Ai, Zeyu and Dai, Ping and He, Kangnan and Nie, Ruilong and Zou, Shimin and Chen, Liang},
  title = {Navigating the Gut–Prostate Axis: The Gut Microbiome in Prostate Cancer Resistance and Targeted Interventions},
  journal = {Microbiology Research},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {55},
  doi = {10.3390/microbiolres17030055}
}
Kostenlos starten →